
Prabu Nambiar, Ph.D., Founder, & CEO, Syner-G BioPharma Group Despite years of work and breakthroughs in technology and data mining,bringing a drug from bench to bedside remains a costly, complex, and time-consuming process.With long lead times, chemistry, manufacturing, and controls (CMC) often become the bottleneck in the path to life-saving drug launch and their commercial […]